# US 2016/0258005 A1 · Methods for rapid ribonucleic acid fluorescence in situ hybridization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0258005 A1
- Document ID: US20160258005A1
- Status: Published application
- Kind: A1
- Application number: 14/900,494
- Filed: 2014-07-01
- Published: 2016-09-08
- Earliest claimed: 2013-07-02
- Assignees: The Trustees of the University of Pennsylvania
- Applicants: The Trustees of the University of Pennsylvania
- Inventors: Arjun RAJ; Sydney Shaffer; David Issadore
- Web page: https://patentgrep.com/patent/US20160258005A1

## CPC

- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6841: In situ hybridisation
- C12Q 1/701: {Specific hybridization probes}
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides a method for improved fluorescent in situ hybridization (FISH) methodology which allows for quantifiable signals to be obtained in a short period of time. In certain embodiments, the method provides for a shorter hybridization time, thereby allowing the present method to be used in screening and rapid diagnostic methods. The present invention also provides a device and reagents for use with the methods of the invention.

## Claims

### Claim 1

A method for a rapid detection of a target nucleic acid in a sample, the method comprising:
contacting the sample with a non-crosslinking fixative, thereby producing a fixed sample;
contacting the fixed sample with a hybridization solution, the hybridization solution comprising at least one labeled probe which hybridizes to a region of the target nucleic acid, wherein the detection of the labeled probe indicates the detection of the target nucleic acid in the sample; and
wherein the detection method is conducted in less than 5 hours.

### Claim 2 (depends on 1)

The method of claim 1, wherein the non-crosslinking fixative comprises an alcohol selected from the group consisting of ethanol and methanol.

### Claim 3 (depends on 1)

The method of claim 1, wherein the target nucleic acid is RNA.

### Claim 4 (depends on 1)

The method of claim 1, wherein the target nucleic acid comprises a mutational variant.

### Claim 5 (depends on 1)

The method of claim 1, wherein the sample is obtained from a mammal.

### Claim 6 (depends on 5)

The method of claim 5, wherein the mammal is a human.

### Claim 7 (depends on 1)

The method of claim 1, wherein the one labeled probe concentration is about 0.1 mM to about 20 mM.

### Claim 8 (depends on 1)

The method of claim 1, wherein the one labeled probe concentration is about 3 mM to about 4 mM.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sample is contacted with the non-crosslinking fixative for about 10 minutes.

### Claim 10 (depends on 1)

The method of claim 1, wherein the sample is contacted with the non-crosslinking fixative for about 2 minutes.

### Claim 11 (depends on 1)

The method of claim 1, wherein the fixed sample is contacted with the hybridization solution for less than about 2 hours.

### Claim 12 (depends on 1)

The method of claim 1, wherein the fixed sample is contacted with the hybridization solution for less than about 1 hour.

### Claim 13 (depends on 1)

The method of claim 1, wherein the fixed sample is contacted with the hybridization solution for less than about 10 minutes.

### Claim 14 (depends on 1)

The method of claim 1, wherein the fixed sample is contacted with the hybridization solution for less than about 1 minutes.

### Claim 15 (depends on 1)

The method of claim 1, wherein the fixed sample is contacted with the hybridization solution for less than about 30 seconds.

### Claim 16 (depends on 1)

The method of claim 1, wherein the detection method is conducted in less than 2 hours.

### Claim 17 (depends on 1)

The method of claim 1, wherein the detection method is conducted in less than 10 minutes.

### Claim 18 (depends on 1)

The method of claim 1, wherein the detection method is conducted in less than 5 minutes.

### Claim 19 (depends on 1)

The method of claim 1, wherein the at least one probe is labeled with a fluorophore.

### Claim 20 (depends on 19)

The method of claim 19, further comprising detecting the fluorophore.

### Claim 21 (depends on 3)

The method of claim 3, wherein the RNA is selected from the group consisting of messenger RNA, intronic RNA, exonic RNA, and non-coding RNA.

### Claim 22 (depends on 1)

The method of claim 1, wherein the method is used to quantify the presence of the target nucleic acid.

### Claim 23 (depends on 1)

The method of claim 1, wherein the method is used to investigate chromosome structure and transcriptional activity.

### Claim 24 (depends on 1)

The method of claim 1, wherein the method is used to identify a mutation in the target nucleic acid.

### Claim 25 (depends on 1)

The method of claim 1, wherein the method is used in high-throughput screening.

### Claim 26 (depends on 1)

The method of claim 1, wherein the method is used in rapid diagnostics.

### Claim 27 (depends on 1)

The method of claim 1, wherein the target nucleic acid comprises an viral nucleic acid sequence.

### Claim 28 (depends on 27)

The method of claim 27, wherein the viral nucleic acid comprises an influenza nucleic acid sequence.

### Claim 29 (depends on 1)

The method of claim 1 wherein, the probe is one or more oligonucleotides depicted at FIGS. 23, 24, 35, and 26 (SEQ ID NOs:1-961).

### Claim 30 (depends on 1)

The method of claim 1, comprising the use of a microfluidics device, the microfluidics device comprising one or more openings in fluid communication with one or more liquid reservoirs or wells.

### Claim 31 (depends on 30)

The method of claim 30, wherein the microfluidics device is optically transparent.

### Claim 32 (depends on 30)

The method of claim 30, wherein the sample is introduced into a liquid reservoir or well of the microfluidics device.

### Claim 33 (depends on 30)

The method of claim 30, comprising introducing a fluid into the liquid reservoir or well.

### Claim 34 (depends on 30)

The method of claim 30, wherein the fluid comprises one or more of a labeled probe, a non-crosslinking fixative, or a buffer.

### Claim 35 (depends on 30)

The method claim 30, wherein the microfluidics device comprises the labeled probe preloaded into a liquid reservoir or well.

### Claim 36

A method for a rapid detection of an influenza target nucleic acid in a cell from a biological sample, the method comprising:
contacting a cell of the sample with a non-crosslinking fixative, thereby producing a fixed cell;
contacting the fixed cell with a hybridization solution, the hybridization solution comprising at least one labeled probe which hybridizes to a region of the influenza target nucleic acid, wherein the detection of the labeled probe indicates the detection of the influenza target nucleic acid in the cell; and
wherein the detection method is conducted in less than 5 hours.

### Claim 37 (depends on 36)

The method of claim 36, wherein the non-crosslinking fixative comprises an alcohol selected from the group consisting of ethanol and methanol.

### Claim 38 (depends on 36)

The method of claim 36, wherein the target nucleic acid is RNA.

### Claim 39 (depends on 36)

The method of claim 36, wherein the target nucleic acid comprises a mutational variant.

### Claim 40 (depends on 36)

The method of claim 36, wherein the sample is obtained from a mammal.

### Claim 41 (depends on 40)

The method of claim 40, wherein the mammal is a human.

### Claim 42 (depends on 36)

The method of claim 36, wherein the one labeled probe concentration is about 0.1 mM to about 20 mM

### Claim 43 (depends on 36)

The method of claim 36, wherein the one labeled probe concentration is about 3 mM to about 4 mM

### Claim 44 (depends on 36)

The method of claim 36, wherein the labeled probe is one or more oligonucleotides depicted at FIGS. 23, 24, 35, and 26 (SEQ ID NOs:1-961).

### Claim 45 (depends on 36)

The method of claim 36, wherein the sample is contacted with the non-crosslinking fixative for about 10 minutes.

### Claim 46 (depends on 36)

The method of claim 36, wherein the sample is contacted with the non-crosslinking fixative for about 2 minutes.

### Claim 47 (depends on 36)

The method of claim 36, wherein the fixed sample is contacted with the hybridization solution for less than about 2 hours.

### Claim 48 (depends on 36)

The method of claim 36, wherein the fixed sample is contacted with the hybridization solution for less than about 1 hour.

### Claim 49 (depends on 36)

The method of claim 36, wherein the fixed sample is contacted with the hybridization solution for less than about 10 minutes.

### Claim 50 (depends on 36)

The method of claim 36, wherein the fixed sample is contacted with the hybridization solution for less than about 1 minutes.

### Claim 51 (depends on 36)

The method of claim 36, wherein the fixed sample is contacted with the hybridization solution for less than about 30 seconds.

### Claim 52 (depends on 36)

The method of claim 36, wherein the detection method is conducted in less than 2 hours.

### Claim 53 (depends on 36)

The method of claim 36, wherein the detection method is conducted in less than 10 minutes.

### Claim 54 (depends on 36)

The method of claim 36, wherein the detection method is conducted in less than 5 minutes.

### Claim 55 (depends on 36)

The method of claim 36, wherein the at least one probe is labeled with a fluorophore.

### Claim 56 (depends on 55)

The method of claim 55, further comprising detecting the fluorophore.

### Claim 57 (depends on 36)

The method of claim 36, wherein the RNA is selected from the group consisting of messenger RNA, intronic RNA, exonic RNA, and non-coding RNA.

### Claim 58 (depends on 36)

The method of claim 36, wherein the method is used to quantify the presence of the target nucleic acid.

### Claim 59 (depends on 36)

The method of claim 36, wherein the method is used to investigate chromosome structure and transcriptional activity.

### Claim 60 (depends on 36)

The method of claim 36, wherein the method is used to identify a mutation in the target nucleic acid.

### Claim 61 (depends on 36)

The method of claim 36, wherein the method is used in high-throughput screening.

### Claim 62 (depends on 36)

The method of claim 36, wherein the method is used in rapid diagnostics.

### Claim 63 (depends on 36)

The method of claim 36, wherein the target nucleic acid comprises an viral nucleic acid sequence.

### Claim 64 (depends on 63)

The method of claim 63, wherein the viral nucleic acid comprises an influenza nucleic acid sequence.

### Claim 65 (depends on 36)

The method of claim 36, comprising the use of a microfluidics device, the microfluidics device comprising one or more openings in fluid communication with one or more liquid reservoirs or wells.

### Claim 66 (depends on 65)

The method of claim 65, wherein the microfluidics device is optically transparent.

### Claim 67 (depends on 65)

The method of claim 65, wherein the sample is introduced into a liquid reservoir or well of the microfluidics device.

### Claim 68 (depends on 65)

The method of claim 65, comprising introducing a fluid into the liquid reservoir or well.

### Claim 69 (depends on 65)

The method of claim 65, wherein the fluid comprises one or more of a labeled probe, a non-crosslinking fixative, or a buffer.

### Claim 70 (depends on 65)

The method claim 65, wherein the microfluidics device comprises the labeled probe preloaded into a liquid reservoir or well.

### Claim 71

A fluidic device for detection of influenza in a sample, the fluidic device comprising one or more openings in fluid communication with one or more liquid reservoirs or wells, wherein the liquid reservoirs or wells comprise one or more labeled probes depicted at FIGS. 23, 24, 35, and 26 (SEQ ID NOs:1-961).

### Claim 72

A kit comprising at set of probes for detection of nucleic acids in a sample and instructions for use thereof.
